#United States #Civica #Lehi #Veterans Affairs #Generic Medicines

Civica Awarded Major Contract with the US Department of Veterans Affairs

Civica, a non-profit pharmaceutical company focused on addressing the severe issue of generic drug shortages, has recently been awarded a significant contract by the U.S. Department of Veterans Affairs (VA). Under this contract, Civica will supply essential generic medications to various healthcare facilities operated by the VA, which includes medical centers and outpatient clinics. This partnership marks a crucial step toward ensuring that veterans receive necessary medications safely and without interruption.

Understanding the Contract

The contract, known as the Federal Supply Schedule (FSS), allows Civica's products to be procured through the VA Federal Supply Schedule Program. This means that their generic medications will be readily available for all VA medical centers, outpatient clinics, and other federal entities such as the Department of Defense (DoD). Civica's commitment ensures that the VA will have access to over 70 essential medications, which are part of the FDA's Drug Shortages Database.

Jennifer Spalding, Civica’s Chief Commercial Officer, expressed pride in being chosen as a partner by the VA. She emphasized the importance of providing a consistent supply of essential medicines, which will not only benefit veterans but also enhance the overall healthcare system. Civica aims to fill a critical gap and help alleviate the burdens of drug shortages that hospitals frequently face.

The Challenge of Drug Shortages

Drug shortages are a recurring challenge in the U.S. healthcare industry, impacting patient care and access to essential treatments. The American Society of Hospital Pharmacists has reported numerous drugs in short supply, especially sterile injectables critical in urgent care scenarios. Such shortages often lead healthcare facilities to divert significant resources, including time and funds, to source alternative medications, which can disrupt treatment protocols.

Civica was established in 2018 with a mission to improve the accessibility and affordability of essential medicines. It is composed of a coalition of healthcare organizations, including leading hospitals and philanthropy groups. By focusing on long-term contracts and maintaining safety stock, Civica aims to stabilize the market and mitigate the impacts of drug shortages, ultimately benefiting countless patients.

Impact on the Healthcare System

The Veterans Health Administration (VHA) operates the largest integrated healthcare system in the United States, encompassing 170 medical centers and approximately 1,193 outpatient clinics. Civica's collaboration with such an extensive network is expected to have a profound impact on the health and well-being of millions of veterans and their families.

By ensuring a steady supply of vital medications, Civica plays a crucial role in safeguarding the health of those who have served the nation. The inclusion of Civica's generics in the VA's formulary not only supports better health outcomes but also alleviates potential crises arising from drug shortages.

A Commitment to Excellence

Civica's dedication to providing quality generic drugs highlights how the pharmaceutical industry can proactively address pressing challenges within the healthcare sector. The company's unique approach, which involves collaboration with various stakeholders to ensure the production of high-quality generics, sets an important precedent for how to manage medicine shortages effectively.

In conclusion, Civica’s new partnership with the VA demonstrates a significant commitment to improving healthcare accessibility for veterans. By providing essential generic medicines, Civica not only enhances the stability of drug supplies but also reaffirms its mission of delivering affordable healthcare solutions to the U.S. population. This partnership is a promising step forward in resolving the ongoing issues of drug shortages that affect the healthcare system at large.